HHLR ADVISORS, LTD.HHLR ADVISORS, LTD.

Institutional investor · Portfolio as of Q1 2020

SEC EDGAR SourceSEC Filings

Top Holdings60 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

ZOOM COMMUNICATIONS INC

6.2M$905.1M12.2%$66.79+125.90%
2 qtrssince 2019-Q4
Decreased
0
IQIQ
ADR

IQIYI INC

46.7M$831.2M11.2%$18.39+1.46%
6 qtrssince 2018-Q4
Unchanged
0
ONCONC
ADR

BEIGENE LTD-ADR

5.5M$673.7M9.1%$134.02-6.44%
6 qtrssince 2018-Q4
Unchanged
0

UBER TECHNOLOGIES INC

19.3M$537.8M7.2%$29.72-6.36%
3 qtrssince 2019-Q3
Increased
74
JDJD
ADR

JD.COM INC-ADR

11.9M$482.2M6.5%$20.17+81.71%
6 qtrssince 2018-Q4
Unchanged
0
TALTAL
ADR

TAL ED GROUP

7.5M$399.7M5.4%$30.74+69.18%
6 qtrssince 2018-Q4
Decreased
0
BABABABA
ADR

ALIBABA GROUP HOLDING-SP ADR

2M$385M5.2%$138.98+31.69%
6 qtrssince 2018-Q4
Unchanged
0
PDDPDD
ADR

PDD HOLDINGS INC

8.7M$314.5M4.2%$25.15+41.67%
6 qtrssince 2018-Q4
Unchanged
0
CBCBPODelisted

CHINA BIOLOGIC PRODS HLDGS I

2.8M$296.9M4.0%
6 qtrssince 2018-Q4
Unchanged
0
ESGRESGRDelisted

ENSTAR GROUP LIMITED

1.7M$278M3.7%
5 qtrssince 2019-Q1
Unchanged
0
BILIBILI
ADR

BILIBILI INC-SPONSORED ADR

10.2M$239.2M3.2%$15.50+48.16%
6 qtrssince 2018-Q4
Unchanged
0

ALIGN TECHNOLOGY INC

1.1M$185.5M2.5%$209.25-14.02%
3 qtrssince 2019-Q3
Decreased
0
VIEVIEDelisted

VIELA BIO INC

4.6M$174.5M2.4%
2 qtrssince 2019-Q4
Unchanged
0

Kyntra Bio, Inc.

4M$137.5M1.9%

BRIDGEBIO PHARMA INC

4.7M$136.6M1.8%$23.99+11.15%
4 qtrssince 2019-Q2
Increased
51
APLSAPLSDelisted

APELLIS PHARMACEUTICALS INC

5M$134.7M1.8%$19.43+47.64%
6 qtrssince 2018-Q4
Increased
51

MONDELEZ INTERNATIONAL INC-A

2.5M$127.5M1.7%$33.70+31.57%
6 qtrssince 2018-Q4
Unchanged
0
VIPSVIPS
ADR

VIPSHOP HLDGS LTD

7M$109.8M1.5%$14.080.00%
1 qtr
New
69
BPMCBPMCDelisted

BLUEPRINT MEDICINES CORP

1.6M$94.3M1.3%
6 qtrssince 2018-Q4
Increased
51
ZTOZTO
ADR

ZTO EXPRESS CAYMAN INC

3.4M$90.9M1.2%$23.130.00%
1 qtr
New
68
$7.4B
AUM
60
Positions
Q1 2020
Filing
Rating · 2.0
Quarterly Portfolio Change
+49%Q1'19$3.6B+25%Q2'19$4.5B+63%Q3'19$7.3B+10%Q4'19$8B-8%Q1'20$7.4B
Activity profile
$ moved · Q1'20
New23%Increased7%Decreased63%Exited7%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.6 quarters
<1Q12%1-4Q38%1-2Y42%2Y+8%

HHLR ADVISORS, LTD. manages $7.4B across 60 positions as of Q1 2020. Top holdings: ZM (12.2%), IQ (11.2%), ONC (9.1%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.

Q1 2020 Summary

Active quarter - 9 new positions, 3 exits, 5 increased. Top move: UBER (INCREASED, conviction 74). Portfolio: $7.4B across 60 positions.

Top holdings by portfolio weight

Total AUM$7B
ZM12.20%
IQ11.20%
ONC9.08%
UBER7.25%
JD6.50%
TAL5.39%
BABA5.19%
PDD4.24%
CBPO4.00%
ESGR3.75%
Other3.22%

Portfolio allocation by GICS sector

Sectors8
Healthcare21.75%
Technology20.69%
Consumer Cyclical19.75%
Communication Services15.21%
Unknown14.02%
Consumer Defensive7.11%
Industrials1.23%
Financial Services0.24%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Technology, Consumer Cyclical
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track RecordNo data
Conviction42
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used